Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

DEXTROSE INJECTION

Closed
SPE2DP-26-T-4163Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Dextrose Injection, USP, 5% in 50 mL units, packaged in quantities of 80 per package, is being procured under solicitation SPE2DP-26-T-4163 by the Department of Defense through DLA Troop Support’s Medical Supply Chain Pharmacy Field Support Activity. The item is regulated by the FDA and must be delivered to Fort Stewart, Georgia, with a delivery window of 20 days after order placement, FOB destination, and zero variance allowed in quantity. The unit of issue is the package (PG), with each package containing 80 individual units. The contractor must comply with Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129 for all medical acquisitions, and packaging must conform to MIL-STD-2073-1E for preservation, packing, and marking. Each unit must be sealed in protective commercial packaging to prevent breakage, and exterior shipping containers must be suitable for safe, cost-efficient transport by common carrier. The product has a fixed, non-extendable shelf life of 24 months as a Type I (Code M) item and must be labeled accordingly. Hazardous material labeling must align with OSHA’s Hazard Communication Standard, and all shipments must be tracked using WAWF for electronic invoicing and receiving reports. No payment or pricing data is provided in the solicitation, and the contract type remains undetermined. Offerors must have a current Unique Entity ID and CAGE code, disclose socioeconomic status if claiming small business or designated category status, and comply with cybersecurity requirements under NIST SP 800-171, as well as provisions prohibiting trafficking in persons, mandatory arbitration agreements, and acquisition of certain Chinese military company products. All quotes must be submitted electronically via DIBBS by July 22, 2026. Inspection and acceptance will occur at the delivery point, and the government retains the right to reject noncompliant supplies.

General Info

Procure 5% Dextrose 50 mL, 80 units/pack, FDA-compliant, 24-month shelf life, deliver to Fort Stewart by July 22, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4163 Medical Supply Chain Pharma

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
DEXTROSE INJECTION
DEXTROSE INJECTION, USP, 5 % DEXTROSE, 50 ML,80S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
UNIT ISSUE IS PACKAGE
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 80 EA
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-4163
SECTION B
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORP IV 04687 P/N 2B0040 BAXTER HEALTHCARE CORP IV 04687 P/N NDC00338-0551-11
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017505605 0001 PG 1.000
NSN/MATERIAL:6505013859466
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-385-9466 Quantity: 1 PG Purchase Request: 7017505605QTY: 1 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS